ArticleClinical proteomics2023

Comment on "Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosis. Clinical Proteomics".

Fereshteh Behdarvand Dehkordi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.